Irinotecan is an anti-cancer drug used in the treatment of advanced colorectal cancer. It is a chemotherapy drug which belongs to a class of drugs known as topoisomerase inhibitors. It works by blocking the action of an enzyme in cancer cells that helps them to grow and divide. Irinotecan is usually given in combination with other chemotherapy drugs and is usually given intravenously in hospital. Side effects can include nausea and vomiting, hair loss, diarrhoea, low white blood cell counts, and fatigue.
Irinotecan is a powerful medication used to treat specific types of cancer. Here's a comprehensive overview:
Purpose:
- Primarily used to treat colorectal cancer, either alone or combined with other chemotherapy drugs.
- May also be used for other cancers like:
- Small cell lung cancer (in combination with other medications)
- Pancreatic cancer (under specific conditions)
Mechanism of Action:
- Belongs to the class of drugs called topoisomerase I inhibitors.
- Disrupts the process of DNA replication within cancer cells, hindering their growth and division.
Administration:
- Administered intravenously (through a vein) by a healthcare professional.
- Dosage and treatment schedule are determined by the doctor based on individual needs and factors.
Important Considerations:
- Prescription medication: Only available with a doctor's prescription and close medical supervision.
- Severe side effects: Can cause serious side effects, including:
- Diarrhea
- Low blood cell counts
- Nausea and vomiting
- Hair loss
- Increased risk of infection
- Not for everyone: May not be suitable for individuals with certain pre-existing medical conditions or allergies.
Disclaimer:
- I am not a medical professional and this information should not be interpreted as medical advice.
- Never attempt to self-medicate with Irinotecan.
- Always consult with a licensed physician regarding cancer treatment options. They can assess your individual situation, determine if Irinotecan is appropriate for your specific case, and provide the necessary guidance and monitoring throughout the treatment process.
Here are some reliable resources for further information:
- MedlinePlus: https://medlineplus.gov/druginfo/meds/a608043.html
- National Cancer Institute: https://www.cancer.gov/
- American Cancer Society: https://www.cancer.org/